Cannabinoid Ratio Instability
Cannabinoid ratio instability refers to phenotypic variation in the relative concentrations of THC, CBD, and minor cannabinoids within a strain family across generations or individual plants. This trait occurs when genetic loci governing cannabinoid synthase enzymes segregate unpredictably, resulting in inconsistent chemotype expression even from clones or stabilized seed lines. Breeders working in this category often observe offspring that deviate significantly from parent cannabinoid profiles, complicating product standardization. The phenomenon is particularly common in crosses involving diverse landrace genetics or F1 hybrids where cannabinoid pathway genes haven't been fully fixed. Understanding this instability is critical for breeding programs targeting reproducible cannabinoid ratios for research and commercial cultivation.
Cannabinoid Ratio Instability strains
No strains tagged into Cannabinoid Ratio Instability yet — they'll appear here as breeders submit lineage records under this family.
Cannabinoid ratio instability refers to phenotypic variation in the relative concentrations of THC, CBD, and minor cannabinoids within a strain family across generations or individual plants. This trait occurs when genetic loci governing cannabinoid synthase enzymes segregate unpredictably, resulting in inconsistent chemotype expression even from clones or stabilized seed lines. Breeders working in this category often observe offspring that deviate significantly from parent cannabinoid profiles, complicating product standardization. The phenomenon is particularly common in crosses involving diverse landrace genetics or F1 hybrids where cannabinoid pathway genes haven't been fully fixed. Understanding this instability is critical for breeding programs targeting reproducible cannabinoid ratios for research and commercial cultivation.
Breeders addressing cannabinoid ratio instability typically employ multi-generational backcrossing and phytochemical screening to isolate and stabilize desired chemotypes. Seed companies often use HPLC or chromatographic testing to identify stable phenotypes before release, reducing market variability.
Educational reference · Cultivar metadata only · No medical claims